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Background: Vascular permeability factor/vascular endo- 
thelial growth factor (VPF/VEGF) is a potent inducer of 
new blood vessel growth (angiogenesis) that contributes to 
the pathology of many angiogenesis-associated disease 
states such as psoriasis, rheumatoid arthritis and cancer. Few 
molecular entities capable of binding to VPF/VEGF with 
high affinity and specificity have been described to date. 
Results: Nuclease-resistant 2’-amino-2’-deoxypyrimi- 
dine nucleotide RNA (2’-aminopyrimidine RNA) 
ligands that bind toVPF/VEGF with high affinity have 
been identified by iterative rounds of affinity- 
selection/amplification from two independent random 
libraries. The sequence information that confers high 
affinity binding toVPF/VEGF is contained in a contiguous 
stretch of 24 nucleotides, 5’-CCCUGAUGGUAGAC- 
GCCGGGGUG-3’ (2’-aminopyrimidine nucleotides are 
designated with italic letters). Of the 14 ribopurines in 
this minimal ligand, 10 can be substituted with the 
corresponding 2’-0-methylpurine nucleotides without a 
reduction in binding affinity toVPF/VEGF. In fact, the 2’- 
O-methyl substitution at permissive positions leads to a 
-17-fold improvement in the binding affinity to 
VPF/VEGEThe higher affinity results from the reduction 
in the dissociation rate constant of the 2’-O-methyl-sub- 
stituted RNA ligand from the protein compared to the 
unsubstituted ligand. The 2’-O-methyl-substituted 
minimal ligand, which folds into a bulged hairpin motif, is 
also more thermally stable than the unsubstituted ligand. 
Nuclease resistance of the ligand is further improved by 
the 2’-O-methyl substitutions and the addition of short 
phosphorothioate caps to the 3’- and 5’-ends. 
Conclusions: We have used the SELEX (systematic 
evolution of Jigands by exponential enrichment) process 
in conjunction with post-SELEX modifications to define 
a highly nuclease-resistant oligonucleotide that binds to 
VPF/VEGF with high affinity and specificity 
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Introduction 
Growth and metastasis of malignancies is dependent on 
the development of new blood vessels, or angiogenesis 
[1,2]. In addition to other abnormal features, tumor- 
associated vasculature is considerably more permeable to 
plasma fluid and protein than the vasculature of normal 
tissues [3,4].This observation has led to the discovery of 
vascular permeability factor (VPF) as a tumor-secreted 
protein that in very low amounts induces a rapid increase 
in vascular permeability independent of mast-cell 
degranulation or endothelial-cell damage [5-71. Several 
groups have subsequently and independently isolated a 
growth factor from pituitary follicular [S,9] and glioma 
tumor cell conditioned media [lo] that was selectively 
mitogenic for vascular endothelial cells; this protein was 
named vascular endothelial growth factor (VEGF) [8]. 
VPF andVEGF were soon shown to be encoded by the 
same gene, which gives rise to four protein isoforms 
(121-, 165-, 189- and 206-amino-acid species) as a result 
of alternative splicing of mRNA [l I-14].VPF/VEGF is 
a secreted N-glycosylated disulfide-linked homodimer 
that exerts its effects on endothelial cells by binding to 
tyrosine kinase receptors encoded by the flt and the 
flk-l/KDR genes [15-171. 
The ability to produce and secreteVPF/VEGF is shared 
by many, if not most, tumor cells [5-7,10,18-22].There 
is now considerable evidence that VPF/VEGF secreted 
by tumors acts in a paracrine manner on the adjacent 
endothelial cells [23,24]. Recently, direct evidence that 
VPF/VEGF contributes to the growth of solid tumors 
has been obtained: neutralizing antibodies toVPF/VEGF 
[19] and a transfected dominant-negative VPF/VEGF 
receptor [25] were found to inhibit the growth of 
xenografted human tumor cell lines in immunocompro- 
mized mice. Elevated levels of VPF/VEGF have also 
been found in sera of cancer patients [26]. 
Since disregulated proliferation of blood vessels con- 
tributes to the pathology of many other disease states 
including psoriasis, rheumatoid arthritis and retinopathies 
[2] in whichVPF/VEGF may be important, there is a 
substantial impetus for the discovery of specific and 
potent ligandsiantagonists ofVPF/VEGF. 
The ease with which nucleic acid libraries of enormous 
size can be generated and screened for molecules with 
unique functional properties has recently led to the 
emergence of the SELEX (systematic evolution of 
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ligands by Bponential enrichment) combinatorial 
chemistry process as one of the most efficient methods 
of discovering new therapeutic and diagnostic candi- 
dates. In the few years since the SELEX process was first 
described, a large number of nucleic acid sequences 
with unique binding or catalytic properties has been 
described (reviewed in [27,28]).The remarkable success 
of SELEX is a salient illustration of the diversity of mol- 
ecular features embodied in random nucleic acid 
libraries. Recently, we and others have shown that 
SELEX is not confined to the use of natural RNA and 
DNA libraries [29-311. With the understanding that the 
modifications in nucleic acids are acceptable as long as 
the substrate requirements of the relevant enzymes are 
met, various chemical moieties can be introduced with 
the aim of providing the libraries with an expanded 
repertoire of functional groups and/or of imparting 
increased nuclease resistance. 
We have previously reported the use of the SELEX 
process to identify specific high affinity RNA ligands to 
VPF/VEGF from a random RNA library [32]. In this 
report, we describe the identification of nuclease-resistant 
modified RNA ligands toVPF/VEGF from two indepen- 
dent 2’-amino-2’-deoxypyrimidine nucleotide RNA (2’- 
aminopyrimidine RNA) libraries. We demonstrate that 
the stability in biological fluids as well as the affinity and 
specificity of the initial lead compound forVPF/VEGF 
can be further improved by post-SELEX modifications. 
Results 
Selection of high-affinity ligands 
High affinity 2’-aminopyrimidine RNA ligands to 
VPF/VEGF were selected from two random libraries (A 
and B) in independent SELEX experiments. In these 
libraries, randomized regions of length 30 and 50 were 
flanked by different fixed-sequence regions (see 
Materials and methods). The initial affinity selections 
in both SELEX experiments were performed with 
=6 x lOI RNA molecules (1 nmol). After 11 rounds 
of affinity selection and amplification, the affinity 
improvement was about loo-fold (data not shown). We 
identified 79 unique-sequence isolates from the affinity- 
enriched pools (44 from library A and 35 from library 
B) as described [33]. Th ese isolates were screened for 
VPF/VEGF binding by measuring the fraction of RNA 
bound to nitrocellulose filters at varying VPF/VEGF 
concentrations. Those that were retained efficiently on 
nitrocellulose filters in the absence of VPF/VEGF (36 
clones) were not considered further. The remaining 43 
ligands bound to VPF/VEGF with estimated dissocia- 
tion constant (Kd) values ranging from lo-lo to lOpa M; 
the rando’m pool had a K, value of =10p7 M.The high- 
affinity ligands to VPF/VEGF fall into several sequence 
families, typically containing isolates from both library A 
and library B. In the example shown in Figure 1, a 17- 
nucleotide stretch of highly conserved consensus 
primary structure is apparent. Extensive base-pairing 
covariation is observed between positions 1 and 23, 2 
and 22, and 3 and 21; modest base-pairing covariation is 
seen between positions 4 and 20 (1 A-U and 5 C-G). 
Dot-matrix analysis of the consensus secondary structure 
To facilitate the detection of consensus secondary struc- 
tures for nucleic acids, we have developed a method for 
simultaneously examining all possible base pairings in 
aligned sequence sets through the use of dot-matrix rep- 
resentation (Fig. 2) [34]. To produce the matrix, the 
sequence of the oligonucleotide is written as a column 
to define the x-axis and as a row to define the y-axis 
[35]. A symbol (dot) is placed in the matrix at all posi- 
tions where base pairing occurs (G-U and U-G base 
pairs are allowed in this analysis). Double-helix (stem) 
regions are recognized as runs of adjacent bars perpen- 
dicular to the symmetry diagonal. By overlaying the 
aligned dot matrices of all ligands in the set, it is possible 
to identify positions where base pairing is conserved 
(shown in clear (background), blue and red, in order of 
;. . . ;. . . .;9 .. .;: . . .“19 . . .“r” 
14A GCAACAGAGGCVGAUGGLTAGACGCCGGCCAuu -- --- 
17A aAGAGUCGCVGA@%AGACGCCGGCGGAUCuu --- 
23A -G~6GAli%CAGACGCCGGCCY3AAGACA -- 
24A a~iikA6%AGACWCGGGGUGCCGGAA 
23B CAVAGGCuVACAACAGAGCGGGGGLrUCVGAE~%'+GAC'?===kCC 
51B gau c -ij &~E~~A~E~GA~~~~~CA~CAGGCCAAG~~~CACAGAUC~=~ 
Consensus: CUGAUGGUAGACGCCGG 
Frequency (out of 6): 56666665666666665 
Fig. 1. Primary structures of a family of high affinity 2’-aminopyrimidine RNA ligands to VPF/VEGF. Aligned sequences isolated from 
the affinity-enriched RNA pools A and B are shown, depicting nucleotides in the evolved region (upper-case letters); also shown are 
nucleotides in the constant region (lower-case letters) that participate in the predicted consensus secondary structure formation (under- 
line arrows). The 2’-aminopyrimidine nucleotides are shown in italic letters. The positions are numbered arbitrarily starting with the first 
shown nucleotide of ligand 24A. The consensus primary structure is shown below the sequence set, with the frequencies of occurrence 
for each of the conserved nucleotides. 
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Fie. 2. Dot-matrix analvsis to facilitate the 
dgection of consensus secondary structure 
in nucleic acids, showing the consensus 
matrix analysis of the aligned sequence set 
in Figure 1. Each sequence in the set is 
written on two sides of a square (left and 
top, 5’-end at the top and left sides), and a 
symbol (diagonal bar) is placed inside the 
square at all positions where base pairing 
occurs (including G-U base pairs). For 
clarity, the aligned sequence set is only 
shown on the left side. Since each base pair 
in a sequence is represented twice, the 
matrix has a symmetry diagonal (top-left to 
bottom-right) that separates it into two tri- 
angles. Double-helical (stem) regions are 
recognized as runs of adjacent bars perpen- 
dicular to the symmetry diagonal. Positions 
within the matrix where base pairing 
occurs more than once are color-coded 
(red: base pairing occurs in all ligands 
(100 %) at that matrix position, purple: 
75 %, blue: 50 %, light-blue: 25 %, and 
clear (background): 0 %). The upper-right 
triangle shows the entire (unfiltered) data 
set; the lower left triangle shows the filtered 
data set, displaying the most highly con- 
served secondary structure elements. The 
secondary structure depicted in the lower- 
left triangle corresponds to the region of the 
sequence set denoted by inverted vertical 
arrows; to show positions where base 
pairing covariation exists, corresponding 
colors are used to highlight the base pairs 
in this double-helical region. 
increasing frequency). Since the information in the 
matrix is redundant, the top triangle is used for the un- 
filtered data set, while the lower triangle shows the most 
highly conserved and stable secondary structure ele- 
ments. The identification of covariation between any two 
positions in a set is also possible by this method [34]. 
Minimal sequence determinations 
The minimal sequence requirement for high affinity 
binding was determined for one of the best ligands (24A) 
in the sequence set shown in Figure 1, using partial alka- 
line hydrolysis followed be affinity selection [32] (see 
Fig. 3).The phosphodiester bonds adjacent (3’) to the 2’- 
aminopyrimidine nucleotides are relatively resistant to 
alkaline hydrolysis [29,31,36], as manifested by the 
absence of bands at those positionsThis allows sequence 
assignment in the absence of external markers from the 
pattern of purine nucleotides in the ligand, but also 
limits the resolution of the boundaries to the nearest 
purine nucleotide. A minimal ligand, 5’-ACCCU- 
GAUGGUAGACGCCGGGGUG-3’ (ligand NX-107; 
2’-aminopyrimidine nucleotides are shown in italic 
letters), was inferred from these experiments. Binding 
affinities of the chemically synthesized minimal ligand 
NX-107 and its transcribed full length analog 24A for 
VPF/VEGF are essentially identical (data not shown). 
Post-SELEX 2’-O-methyl substitutions at purines 
There is now ample evidence that the 2’-aminopyrimi- 
dine RNA is substantially more resistant to degradation 
by nucleases in serum than is unmodified RNA 
[29,31,36]. To further reduce the number of positions 
that are susceptible to ribonuclease cleavage in viva, we 
examined the extent to which the ribopurines in 
ligand NX-107 could be substituted with 2’-O-methyl 
(2’-OMe) purine nucleotides without compromising 
high-affinity binding to VPF/VEGE As the phosphodi- 
ester bonds adjacent to 2’-OMe nucleotides are consid- 
erably more resistant to alkaline hydrolysis than those 
adjacent to ribonucleotides, we could examine the effect 
of the 2’-OMe substitution on binding at multiple 
positions simultaneously. 
The 2’-OMe substitutions at the 14 purine nucleotide 
positions in ligand NX-107 were tested in four ligand 
pools, each with three to four mixed 2’-OMe/2’-OH 
positions (see Materials and methods). Resolution of the 
radiolabeled hydrolytic fragments of one of the partially 
2’-OMe substituted pools (pool A) on denaturing poly- 
acrylamide gels, before and after affinity selection, is 
shown in Figure 4. In the unselected lane, the bands that 
correspond to hydrolysis at positions 9, 12 and 14 are 
notably fainter compared to other purine nucleotide posi- 
tions as a result of the partial 2’-OMe substitution. As 
noted above, the bands that correspond to hydrolysis at 
2’-aminopyrimidine nucleotides are not observed. In the 
7 nM and the 0.7 nMVPF/VEGF selection lanes, the Al4 
band is relatively more intense than in the unselected lane 
(compared, for example, to the G13 band).The Al2 band, 
on the other hand, is less intense in the selected lanes than 
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Fig. 3. Determination of the minimal 
sequence requirement for high-affinity 
binding of ligand 24A to VPFA/EGF. 
Partial alkaline hydrolysis fragments of 
(a) 32P 3’- or (b) 32P 5’-end-labeled 
ligand 24A were generated by incubat- 
ing the RNA in 50 mM bicarbonate 
buffer, pH 9 for 15 min at 90 “C. The 
hydrolytic fragments were resolved on 
denaturing 8 % polyacrylamide gels. 
For the 5’ boundary determined in (a), 
the partially hydrolyzed, 3’Jabeled 
ligand (lane 1) was affinity selected with 
170 nM (lane 2), 17 nM (lane 3), 
1.7 nM (lane 4), or 0.43 nM (lane 5) 
VPF/VEGF. The 3’ boundary shown in 
(b) was determined in the same manner 
with 5’Jabeled ligand (same lane 
assignments as (a)). The absence 
of pyrimidine nucleotide bands (due 
to resistance to alkaline hydrolysis of 
the phosphodiester bonds 3’ to the 
2’-aminopyrimidine nucleosides) allows 
sequence assignment without external 
markers. Arrows indicate the 5’ and 3’ 
boundaries that define the minimal 
ligand. Lowercase and uppercase letters 
indicate nucleotides in the constant and 
evolved sequence regions, respectively, 
and 2’-aminopyrimidine nucleotides are 
shown in italic letters. 
in the unselected lane. The relative intensity of the G9 
band is approximately equal in the selected and unselected 
lanes. These observations suggest a preference for 2’-OH 
adenosine at position 14 and for 2’-OMe adenosine at 
position 12. No preference for either 2’-OMe or 2’-OH 
guanosine is observed at position 9. 
Band intensities were quantitated by phosphorimager 
analysis and expressed as a fraction of total counts 
(pixels) in each lane. Since the partial 2’-OMe substitu- 
tion was split between four ligand pools (see Materials 
and methods), each unsubstituted ribopurine position 
occurs three times.The mean of the three unsubstituted 
normalized band intensity ratios for the unselected 
versus the selected lanes is plotted as a function of 
purine nucleotide position in Figure 4b. These values 
provide a standard against which the effect of the 2’- 
OMe substitution on binding can be quantitated.The 
curvature results from the difference in the extent of 
partial alkaline hydrolysis in the unselected and the 
selected lanes. Normalized band intensity ratios for the 
partially 2’-OMe-substituted positions that are signifi- 
cantly above or below the curve fit line for the unse- 
lected lanes compared with those for the selected lanes 
(Fig. 4b) reveal positions where the 2’-OMe substitu- 
tion reduces (G6, A7, GlO, A14) or enhances (G16) 
binding affinity. 
Binding of minimal ligands to VPFNEGF 
We used this information to synthesize an analog of 
ligand NX-107 in which all but four purine nucleotides 
(G6, A7, GlO, A14) were substituted with the 2’-OMe 
group. To minimize degradation by the exonucleolytic 
pathway, we also added short poly dT segments contain- 
ing four contiguous internucleoside phosphorothioate 
linkages to the 5’ end ([5’P] = d(TsTsTsTs), where s rep- 
resents the phosphorothioate linkage) and the 3’ end 
([3’P] = d(TsTsTsTsT)). The addition of phosphoro- 
thioate caps does not significantly affect binding to 
VPF/VEGF (data not shown). The minimal 2’-OMe- 
substituted ligand with the phosphorothioate caps will be 
referred to as NX-213. Binding of NX-213 to 
VPF/VEGF is compared in Figure 5 to that of the 2’- 
OMe-unsubstituted ligand (NX-178), a ligand in which 
the 2’-OMe substitution pattern in purine nucleotides is 
inverted compared to NX-213 (NX-223), a ligand in 
which all purine nucleotides are 2’-OMe-substituted 
(NX-224) and a ligand in which all nucleotides are 2’- 
OMe-substituted (NX-191). The K, values for these 
ligands are given in Table 1. The 2’-OMe substitution at 
permissive purine nucleotide positions increases the 
binding affinity forVPF/VEGF -17-fold. Conversely, the 
2’-OMe substitution at purine nucleotide positions that 
prefer the 2’-OH group or at all positions in the ligand 
abrogates high-affinity binding. 
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Fig. 4.2’-0-Methylpurine nucleotide interference analysis indicates 
positions that can be substituted without compromising binding 
affinity to VPUVEGF. (a) Minimal VPFiVEGF ligand NX-107 was 
chemically synthesized to contain a mixture of 2’-OMe and 2’-OH 
purine nucleotides at positions 9, 12, and 14, using a 2:l molar 
ratio of 2’-OMe:2’-OH (protected as the t-butyldimethylsilyl ether) 
phosphoramidites (pool A). Other purine nucleotides are unmodi- 
fied (2’-OH) and all pyrimidine nucleotides (shown in italics) are 
2’-amino-modified. The unselected lane shows the partial alkaline 
hydrolysis pattern of the 32P 5’.end-labeled ligand population prior 
to affinity selection resolved on a 20 % polyacrylamide denaturing 
gel. The phosphodiester bonds 3’ to the 2’-aminopyrimidine nucleo- 
sides are essentially resistant to alkaline hydrolysis resulting in the 
absence of bands at those positions (see also Fig. 3). Partial 2’-OMe 
substitution at positions 9, 12, and 14 is reflected in fainter bands 
compared to those of the neighboring ribopurines. The first two 
lanes from the left show the partial alkaline hydrolysis pattern fol- 
lowing affinity selection with 7 nM or 0.7 nM protein. The prefer- 
ence for the 2’-OMe or the 2’-OH group at the three substituted 
positions is deduced from the differences in the relative band inten- 
sities in the affinity-selected versus the unselected ligand pools. For 
example, the preference for the 2’-OH group at position 14 is 
deduced from the ratio of Al4 to Cl3 band intensities, which is 
greater in the affinity-selected lanes than in the unselected lane. 
Similarly, the preference for the 2’-OMe group at position 12 is 
deduced from the ratio of Al2 to G13 band intensities, which is 
lower in the affinity-selected lanes than in the unselected lane. Band 
intensities were quantitated by phosphorimager analysis and the 
data were normalized for differences between lanes and the extent 
of partial alkaline hydrolysis (see (b)). (b) Graphic representation of 
the normalized phosphorimager data for determination of the 2’- 
OMe purine nucleotide substitution pattern. The mean of the three 
normalized band intensity ratios (unselected/selected lanes) for the 
unsubstituted (exclusively 2’-OH) purine positions is shown in open 
circles, with standard deviations. A smooth curve is drawn through 
the data points to guide the eye (y = 0.403ea~sasx); the 95 % confi- 
dence intervals are shown in dashed lines. The equivalent ratio for 
each of the partially substituted purine nucleotide positions is 
shown as filled circles, Ratios for the substituted positions that are 
significantly above or below the curve fit line reveal positions where 
the 2’.OMe substitution reduces (C6, A7, Cl 0, Al 4) or enhances 
(Cl 6) binding affinity, respectively. 
We also determined the dissociation rates for com- 
plexes of ligands NX-178 and NX-213 with 
VPF/VEGF at 37 “C using radiolabeled ligands and 
adding a large molar excess (=500-fold) of the unlab- 
eled ligands (Fig. 5b). For both ligands, the first-order 
rate equation provides an adequate fit to the data 
points. The dissociation rate constants obtained from 
these data were 5.9 rf: 0.7 x 10e2 s-l (t1,2 = 12 s) for 
NX-178 and 1.4 f 0.6 x 1O-3 s-l (t1,2 = 8 min) for 
NX-213. Assuming a simple bimolecular association 
model, the association rate constants of 2.4 rf: 0.6 x 
lo7 M-Is-l for NX-178 and 1.0 k 0.4 x lo7 M-is-l for 
NX-213 were calculated. The 2’-OMe substitution at 
permissive purine nucleotide positions therefore 
decreases the dissociation rate constant =40-fold and 
the association rate constant -2-fold. 
We next tested whether the ligands bind to a biologi- 
cally relevant site on the protein. Figure 5c shows that 
NX-213 inhibits binding of 1251-labeledVPF/VEGF to 
the receptors expressed on human umbilical vein 
endothelial cells (HUVECs) in a concentration-depen- 
dent manner with an ED,, of ~1 nM.The ED,, for the 
control ligand NX-191 is >l I.LM. 
(b) 
__--- 
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Table 1. Dissociation constants (Kds) and melting temperatures (T,s) for minimal ligands derived from clone 24A. 
Ligand Structurea K,, nMb T c “C rnf 
NX-178 5’-[5’P]ACCCUCAUGGUAGACGCCGGGGUG[3’P]-3’ 2.4 % 0.5 39 
NX-190 5’-[5’P]d(ACCCTGATGGTAGACGCCGGGGTG)[3’P]-3’ - 44 
NX-191 5’-[5’P]ACCCUGAUGGUAGACGCCGGGGUG[3’P]-3’ 250+130 73 
NX-213 5’-[5’P]8CCCUGAUcGU&ACGCCCGGGGUG[3’P]-3’ 0.14 f 0.01 46 
NX-223 5’-[5’P]ACCCU~UGGUAG~CGCCGGGGUG[3’PJ-3’ 25OizlOO - 
NX-224 5’-[5’P]ACCCU~UGGUAGACGCCGGGGUG[3’P]-3’ 320+ 70 - 
a2’-Aminopyrimidine nucleotides are designated with italic letters; 2’-OMe purine nucleotides are underlined; [5’P] represents the 5’ cap, 
d(TsTsTsTs), where s represents the internucleoside phosphorothioate linkage, and [3’P] represents the 3’ cap, d(TsTsTsTsT). 
bK, values were determined from the data shown in Figure 5. 
CT, values were determined from the data shown in Figure 8. 
We examined the specificity of NX-178 and NX-213 
binding by measuring their Kds with a panel of heparin- 
binding proteins (Table 2). The affinity of both ligands 
for nativeVPF/VEGF is significantly higher than that for 
any other protein examined. Although the affinity of 
NX-213 for native VPF/VEGF is 17-fold greater than 
that of NX-178, the affinities of these two ligands for 
other proteins are comparable; the improvement in affin- 
ity for native VPF/VEGF is therefore coupled to the 
improvement in specificity. 
Thermal stabilities of minimal ligands 
Melting temperatures (T,s) were determined for 
ligands NX-178, NX-213, NX-190 (the all-DNA 
equivalent of NX-213) and NX-191 from the UV 
absorption versus temperature profiles (Fig. 6). Thermal 
denaturation data were determined at three different 
concentrations for each oligonucleotide and shown to 
be concentration independent from 0.8 to 40 Fg ml-l 
oligonucleotide (data not shown). The T, values 
obtained from the first derivative replots (Fig. 6b) are 
listed in Table 1. The low T, value for ligand NX-178 
is expected based on the known destabilizing effect of 
the 2’-amino group on duplex formation [37-39].The 
2’-OMe substitutions in ligand NX-213, on the other 
hand, lead to a significant (~7 “C) increase in the 
thermal stability. The stabilizing effect of the 2’-OMe 
substitutions on RNA:RNA or RNA:DNA duplex 
formation has been observed previously [40,41] and is 
further evident in the large increase in the T, observed 
in the fully 2’-OMe-substituted molecule, NX-191. 
The thermal transitions observed here correspond to 
the helix-to-coil transitions of the monomeric 
(hairpin) species of oligonucleotides. With NX-213 
and NX-191, we have not detected significant inter- 
molecular duplex formation on non-denaturing poly- 
acrylamide gels; only the monomeric species were 
observed as single bands at nucleic acid concentrations 
up to 400 PM (data not shown). 
Secondary structure of NX-213 
The predicted secondary structure of NX-213 based 
on base-pairing covariation (Fig. l), consensus base- 
pairing analysis (Fig. 2), and preliminary 1D and 2D 
IH NMR data on NX-213 and other analogs (not 
shown) is a bulged hairpin (Fig. 7). The NMR results 
suggest that a stable four-base-pair stem is formed 
involving three G-C base pairs and an A-U base pair 
and that this stem is disrupted at or after U5/G19. 
Interestingly, a longer stem with an additional U-G 
and G-C base pair does not appear to form, or may 
form only transiently. This less stable stem might be a 
result of the 2’-amino modifications, which are known 
to destabilize helical conformations [37-391. 
Table 2. Binding affinities (Kd values) and specificity indices (Kd ProteinlKdVPFNEGF) of NX-178 and NX-213 for native VPF/VEGF, 
reduced VPF/VEGF, platelet-derived growth factor AB (PDGF-A&), basic fibroblast growth factor (bFGF), antithrombin III (ATIII) 
and thrombi+. 
Protein Kd, nM 
NX-178 NX-213 
KdProtein/KdVPF/VECFb 
K,, nM 
KdProtein/KdVPFNEGFb 
VPF/VEGF 2.4 + 0.5 (I .O) 0.14 % 0.01 
Red. VPF/VEGFC 308k89 1.3 x102 280+76 
PDGF-AB 75+21 3.1 x 101 91&30 
bFGF 322 +44 1.3 x102 286%23 
ATIll 192oi92 8.0 x 102 6270+ 559 
Thrombin 3010*259 1.3 x103 3060+106 
aAll K, values were determined by nitrocellulose filter binding. 
bSpecificity index is defined as the ratio of dissociation constants for any protein to native VPF/VEGF. 
CVPF/VEGF was reduced by incubation in 10 mM dithiothreitol for 5 min at room temperature. 
(1 .a 
2.0 x 103 
6.5 x 102 
2.0 x 103 
4.5 x 104 
2.2 x104 - 
I 
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Fig. 5. Modifications at the 2’ positions of SELEX-derived 
ligands alter their affinity for VPF/VEGF. (a) Binding of oligo- 
nucleotide ligands to VPFAIEGF. The fraction of 32P S’-end- 
labeled oligonucleotide bound to varying concentrations of 
VPFiVEGF was determined by the nitrocellulose filter binding 
method. Oligonucleotides tested were ligand NX-213 (0), NX- 
178 (A), NX-223 (a), NX-224 (0) and NX-191 (V). 
Oligonucleotide concentrations in these experiments were 
<SO pM. The lines represent the least squares fit of the data 
points to the binding equation q=f[P]/{[PI+Kd} where q is the 
fraction of protein-bound RNA, [PI is the free protein concen- 
tration and f is the efficiency of retention of the VPFiVEGF-RNA 
complexes on nitrocellulose filters. For ligands NX-223 and 
NX-224, background binding to nitrocellulose in the absence 
of protein amounting to 5 and 14 %, respectively, of the 
maximal signal was observed and was subtracted from all 
values. Each data point represents the average of two determi- 
nations. Binding reactions were done at 37 “C in PBS contain- 
ing 0.01 % HSA. (b) 2’-OMe substitution at permissive purine 
nucleotide positions decreases the dissociation rate of the 
ligand-VPF/VEGF complex. Dissociation of ligands NX-178 (A) 
and NX-213 (0) from VPF/VECF under pseudo first-order con- 
ditions is shown. For each ligand, the fraction of 32P 5’-end- 
labeled ligand bound to VPF/VECF was measured at the 
indicated time points following the addition of SOO-fold excess 
of the unlabeled competitor ligand. The dissociation rate con- 
stant (k,,) was determined by fitting the data points to the first- 
order rate equation [(A-A,)/(!,-A,)] = exp(-k,fft), where A, A, 
and A, represent the normalrzed fractions of RNA bound to 
VPFIVECF at any time (t), t = 0 and t = 00, respectively. The 
experiment was performed at 37 “C in PBS containing 0.01 % 
HSA. (c) Oligonucleotide ligand NX-213 blocks binding of 
1251-VPF/VEGF to cell-surface receptors expressed on human 
umbilical vein endothelial cells (HUVECs). Confluent cultures 
of HUVECs were incubated with 1251-VPF/VEGF (IO ng ml-‘) 
and varying amounts of NX-213 (0) or NX-191 (A) for 2 h at 
4 “C. The amount of cell-associated radioactivity was deter- 
mined as described in the Materials and methods section. Data 
points represent averages of two determinations. 
Nuclease resistance of modified nucleic acid ligands 
To be effective therapeutics, nucleic acid ligands must 
resist rapid degradation by nucleases.To test the effect of 
the addition of phosphorothioate caps and the 2’-OMe 
substitution, we examined the stability of ligands NX- 
107, NX-178 and NX-213 in undiluted rat urine over a 
period of 21 h (Fig. 8). In general, urine has a greater 
capacity to degrade nucleic acid ligands compared to 
serum or plasma.The considerable improvement in sta- 
bility of NX-178 (t1,2 = 17 & 2 h) compared to NX- 
107 (tl,z = 1.4 & 0.1 h) attests to the utility of 
protecting the ligands against degradation by exonucle- 
ases. The 2’-OMe substitution at 10 out of 14 purine 
nucleotides in NX-213 imparts an additional increase in 
ligand stability (t1,2 = 131 + 4 h). Similar results have 
been obtained in other biological fluids and tissues such 
as liver, kidney, brain and spleen (L. Green and N. JanjiC, 
unpublished observations) as well as in preliminary 
pharmacokinetic studies. 
Discussion 
Reproducible identification of VPF/VEGF ligands 
Amplifiable nuclease-resistant oligonucleotide libraries 
are becoming increasingly important in the discovery of 
nucleic acid-based drug candidates. This is largely due 
to the reduction in the number of modifications 
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required to convert lead SELEX-derived compounds 
with desirable in vitro properties into drug candidates 
with favorable bioavailabilities. We have recently 
demonstrated that the ability of the SELEX process to 
reproducibly identify rare nucleic acid ligands that bind 
to bFGF with high affinity is not compromised by the 
use of nuclease-resistant (2’-aminopyrimidine RNA) 
libraries. In the SELEX experiments reported here, we 
observed the emergence of a common consensus 
sequence motif that imparts high-affinity binding 
to VPF/VEGF. It is worth noting that in the 
sequence set shown in Figure 1, the 17-nucleotide 
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Fig. 6. Modifications at the 2’ positions of SELEX-derived ligands 
for VPWEGF alter their thermal stability. Thermal denaturation 
profiles of VPWEGF oligonucleotide ligands. (a) The change in 
absorbance at 260 nm was measured as a function of tempera- 
ture for ligands NX-178 (blue), NX-213 (red), NX-190 (green) and 
NX-191 (black). (b) The first derivatives of the data shown in (a). 
consensus sequence, 5’-CUGAUGGUAGACGCCGG-3’, 
is almost completely conserved, with only three posi- 
tions deviating from the consensus in one out 
of six ligands in the family. The frequency of 
occurrence of the consensus secondary structure 
motif, 5’- NNN CUGA UGSAGA CGSGGN’N’N’ -3’ 
(underlined arrows indicate base pairing), in a region of 
30 (SELEX A) or 50 (SELEX B) contiguous random- 
ized positions is estimated from its information content 
1421 to be 2.5 x lo-l1 or 8.6 x lo-II, respectively. In the 
initial random libraries A and B, which contained about 
6 x 1014 molecules each, this motif is expected to occur 
1.5 x lo4 and 5.2 x lo4 times, respectively. While the 
information content of this motif is not small, we have 
in previous SELEX experiments isolated ligands that 
occur much less frequently [31,32,43]. Ligands with 
this secondary structure motif, given their information 
content, represent a surprisingly small fraction (6/43 or 
14 %) of the VPF/VEGF-binding sequences isolated 
from the affinity-enriched pool. This indicates that 
additional rounds of selection/amplification may result 
in the emergence of ligands with even higher affinities 
forVPF/VEGF that were more sparsely represented in 
the initial random pool. 
Secondary structure analysis 
The detection of consensus primary structure, either by 
inspection or with the aid of multiple sequence align- 
ment algorithms, is generally straightforward for families 
composed of relatively short sequences in which a 
highly conserved sequence region is shared by all 
members (Fig. 1). As a consequence of their functional 
relatedness, all ligands in a family are expected to have 
broadly similar secondary and tertiary structures. The 
consensus secondary structure identification, however, is 
usually considerably more d&cult. The difficulty largely 
comes from the fact that several possible secondary 
structures with comparable predicted free energies 
of folding exist for many individual sequences. 
Nevertheless, the functionally relevant secondary struc- 
ture in a sequence set should be accessible to all ligands. 
The overlayed dot-matrix representation of base pairing 
was developed as a way of simultaneously viewing all 
possible base pairings for all ligands in a family in a 
manner that enhances the common motif by signal 
amplification [34]. The multitude of alternative sec- 
ondary structures is apparent in the unfiltered matrix 
pattern (upper-right triangle in Fig. 2). Note that this 
matrix pattern is characterized not only by strong 
overlap at certain positions but also by a striking lack of 
all possible secondary structures in other regions. The 
restricted spectrum of conformations undoubtedly con- 
tributes to the rigidity of nucleic acid ligands, which is 
expected to have a favorable entropic effect on binding. 
With proper sequence alignment, the consensus sec- 
ondary structure clearly emerges after weaker secondary 
structures are filtered out (lower left triangle, Fig. 2). 
L5’Pl A- ” G - I3’PI 
Fig. 7. The proposed secondary structure of NX-213. Base pairs 
in the more flexible region of the molecule are indicated by open 
circles. 2’-OMe purine nucleotides are underlined and the 
remaining ribopurines are numbered. The 2’-aminopyrimidine 
nucleotides are designated with italic letters. This secondary 
structure is consistent with the consensus secondary structure 
analysis (Figs 1 and 2), the base-pairing covariation analysis and 
the 1 H-NMR data. 
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Fig. 8, Modification of ligands for VPFNECF alters their nuclease 
sensitivity. The stability of ligands NX-107, NX-178 and NX-213 
in rat urine is shown. Aiiquots from the incubation mixtures of 
S’-end-labeled (a) NX-107, (b) NX-178 and (c) NX-213 in sterile 
rat urine were removed at indicated time points and resolved on 
20 % polyacrylamide gels containing 7 M urea. (d) The percent- 
age of the full-length NX-107 (O), NX-178 (A) and NX-213 (0) 
remaining at each time point was determined by phosphor- 
imager analysis. Solid lines represent the least-squares fit of the 
data points to the first-order rate equation. 
Post-SELEX modifications: increased nuclease resistance 
and affinity maturation 
The 2’-OMe interference experiment was initiated pri- 
marily to further increase the in viva stability of the lead 
ligand. Indeed, the partially 2’-OMe-substituted ligand 
NX-213 is considerably more nuclease-resistant than its 
unsubstituted analog (NX-178). All but four of the 
purine nucleotides in the ligand tolerate the 2’-OMe 
substitution. In an analogous interference experiment 
with a SELEX-derived RNA ligand to HIV RT, Green 
et ul. [44] have recently shown that the 2’-OMe group 
could be substituted at all but two positions.These obser- 
vations suggest that this and other similar modification 
interference analyses are generally applicable methods of 
stabilizing SELEX ligands against nuclease degradation. 
Although the permissive 2’-OMe substitution pattern in 
ligand NX-213 was determined on the basis of affinity 
selections and at least one purine nucleotide (G16) 
exhibited a considerable preference for the 2’-OMe 
group (Fig. 5), the increase in binding affinity of 17-fold 
compared to the unsubstituted compound was not 
anticipated. The origin of the 2’-OMe substitution- 
related affinity improvement is at present not clear. The 
design of the interference experiment has allowed us to 
examine the effect of 2’-OMe substitution on binding at 
multiple positions simultaneously. However, since the 
quantitative relationship between the 2’-OMe preference 
index (Fig. 5) and the K, values of singly-substituted 
ligands has not yet been defined, we do not know 
whether the observed improvement in binding of 
NX-213 is due to the 2’-OMe substitution at a few key 
positions (e.g. G16) or to the multiplicative effect of sub- 
stituting most of the purine nucleotides in the molecule. 
Global substitution-related changes such as the increased 
hydrophobic character or the greater thermal stability of 
NX-213 compared to NX-178 could be responsible for 
part of the observed affinity improvement. 
All of the affinity improvement appears to be the result 
of the decrease in the dissociation rate constant of NX- 
213 compared to that of NX-178, since the calculated 
association rate constant of NX-178 is actually about 
two-fold greater than that of NX-213. With values of 
l-3 x lo7 M-Is-l, the association rate constants of these 
ligands are large enough to be close to the diffusion-con- 
trolled limit [45]; a significant improvement in binding 
affinity through a Iarge increase in the association rate is 
therefore improbable. It is worth noting that association 
rates of this magnitude are not unusual for the binding of 
(a) 
(4 
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nucleic acid ligands to their target proteins; for example, 
the value of 1 x lo8 M-Is-’ was obtained for the binding 
of HIV Tat peptide fragment (Tif-38) to its RNA target 
sequence (ATAR) [46] and l-2 x lo8 M-Is-l for the 
binding of tRNA synthetases to their cognate tRNAs 
[45]. For the ligands described here, further improvement 
in binding toVPF/VEGF is more likely to be achieved 
through an additional decrease in the dissociation rate. To 
function as inhibitors of growth-factor signaling, nucleic 
acid ligands must compete with the cell-surface receptors 
for binding to growth factors. Since the dissociation rates 
of many growth factors (including VPF/VEGF) from 
their high affinity receptors are typically very slow 
[47-491, the kinetic stability of the oligonucleo- 
tide-growth factor complexes is expected to be an 
important determinant of inhibitory effectiveness. 
The 2’-OMe interference experiment demonstrates 
that the affinity of SELEX-derived nucleic acid ligands 
can be substantially improved by post-SELEX modifi- 
cations. The notion that the affinity of nucleic acid 
ligands can be increased by modifying the original 
ligand is not new. For example, binding affinity of the 
RNA replicase translational operator to the bacterio- 
phage R17 coat protein was improved =lO-fold upon a 
phosphodiester to phosphorothioate (the Rp isomer) 
substitution at a single position [50] and z-100-fold 
upon a uridine to cytidine substitution, also at a single 
position [51]. The need to improve the affinity of a 
ligand derived from SELEX will be dictated by the 
affinity of the initial lead compounds as well as by the 
intended use of the ligands. For many uses, affinities in 
the low nanomolar range, which are typical for 
SELEX-derived ligands, will be sufficient. In cases 
where it is needed, further affinity enhancement can be 
achieved through secondary SELEX experiments or 
through post-SELEX modifications, using in both 
instances information from the first SELEX experiment 
as a lead. A similar type of affinity-enhancement strat- 
egy is used during an immune response to antigens in 
which antibodies, after the initial gene recombination 
step that generates binding-site diversity, undergo 
somatic mutation of their variable region genes fol- 
lowed by antigen-dependent selection, in a process 
known as affinity maturation [52]. In the example pre- 
sented here, a substantial improvement in affinity for 
VPF/VEGF was achieved with a single type of func- 
tional group, substituting only at the 2’ position. More 
efficient post-SELEX modulation of nucleic acid ligand 
properties is expected with a larger repertoire of func- 
tional groups (including other combinatorial libraries) 
and substitutions over a range of positions in the ligand. 
In a sense, a SELEX-derived nucleic acid ligand can be 
thought of as a precisely constructed scaffold that 
can be subsequently decorated with a wide variety of 
function-modulating chemical moieties. 
As a highly nuclease-resistant modified oligonucleotide, 
NX-213 is a prototype of the next generation of 
SELEX ligands.The effect of binding of ICC-213 on the 
functional properties ofVPF/VEGF in vitro and in vivo is 
currently being examined. 
Significance 
New blood vessel growth (angiogenesis) is increas- 
ingly recognized as an important driving force 
behind many proliferative disorders. As the molecu- 
lar basis of angiogenesis becomes elucidated, the 
opportunity arises to develop pharmacologic agents 
that interfere with the critical events along the 
stimulus-to-response pathway. VPF/VEGF appears 
to be one of the key positive regulators of angio- 
genesis; inhibitors ofVPF/VEGF function may be 
valuable in the therapy of psoriasis, rheumatoid 
arthritis, retinopathies and certain cancers. 
Screening of random nucleic acid libraries with 
the SELEX combinatorial chemistry process has 
recently emerged as a powerful tool for identify- 
ing molecules with useful functional properties. 
For identification of nucleic acid-based drug can- 
didates, the use of nuclease-resistant libraries is 
highly desirable. In this report, we have used the 
SELEX process to identify nuclease-resistant 
2’-aminopyrimidine RNA ligands that bind to 
VPF/VEGF with high affinity. We have also 
demonstrated that the affinity, specificity and 
nuclease resistance can be further improved with 
post-SELEX modifications. With continuing 
improvements in solid-phase oligonucleotide syn- 
thesis, these relatively short oligonucleotides can 
now be synthesized in sufficient amounts to allow 
examination of their potential as diagnostic, 
imaging and therapeutic agents. 
Materials and methods 
Materials 
Recombinant human VPF/VEGF (165-amino-acid isoform) 
was purchased from R&D Systems (Minneapolis, MN) as a 
lyophylized powder free from carrier protein. Recombinant 
human basic fibroblast growth factor, and platelet-derived 
growth factor (AB heterodimer) were also from R&D 
Systems. Human antithrombin III and thrombin were pur- 
chased from Enzyme Research Laboratories (South Bend, 
IN). 2’-Amino-2’-deoxypyrimidine 5’-triphosphates were pre- 
pared in our laboratories as described [53]. The 2’-aminopyr- 
irnidine nucleoside phosphoramidites for solid-phase synthesis 
were prepared by standard methods [54,55] and the 2’-amino 
group was protected as the trifluoroacetyl derivative [56]. 
Synthetic oligonucleotides were prepared on an Applied 
Biosystems Model 394 oligonucleotide synthesizer according 
to the manufacturer’s protocols. 
The SEL EX process 
Iterative rounds of selection/amplification were performed as 
described [31,32]. Briefly, 2’-aminopyrimidine RNA contain- 
ing a randomized region of 30 or 50 nucleotides was prepared 
by in vitro transcription from synthetic DNA templates [57] as 
described [31]. In SELEX experiment A, the starting RNA 
containing 30 randomized positions (5’-gggagacaagaauaacgcu- 
Nuclease-resistant ligands for VPF/VEGF Green et a/. 
caa[30N]uucgacaggaggctrcacaacaggc-3’ (lower-case letters indicate 
the constant regions, italics to indicate 2’-aminopyrimidine 
nucleotides, throughout this paper), was used with the corre- 
sponding primers (5’-d(taatacgactcactatagggagacaagaataacgct- 
caa)-3’ and 5’-d(gcctgttgtgagcctcctgtcgaa)-3’). In SELEX 
experiment B, the starting RNA containing 50 randomized 
positions (5’-gggaggacgaugcgg[5ON]cagacgacucgcccga-3’) was 
used with its corresponding primers (5’-d(taatacgactcac- 
tatagggaggacgatgcgg)-3’ and 5’-d(tcgggcgagtcgtctg)-3’). After in 
vitro transcription the RNA was purified on 8 % polyacryl- 
amide gels containing 7 M urea, eluted from the gel by the 
crush and soak method, alcohol precipitated and resuspended 
in phosphate buffered saline (PBS: 10.1 mM Na2HP04, 
1.8 mM KH,PO,, 137 mM NaCl and 2.7 mM KCl, pH 7.4). 
Prior to incubation withVPF/VEGF, the RNA was heated at 
90 “C for 2 min and cooled on ice. Stock solutions of 
VPF/VEGF were prepared by resuspending the lyophilized 
protein in PBS at concentrations of 5-10 p,M. VPF/VEGF 
stock solution concentrations were determined for each lot 
from the absorbance at 280 nm and the extinction coefficient 
of 1.3 x lo4 M-‘cm-’ for VPF/VEGF dimer. Affinity selections 
were done by incubatingVPF/VEGF with RNA for at least 
15 min at 37 “C in PBS containing 0.01 % human serum 
albumin. Partitioning of free RNA from protein-bound RNA 
was done by nitrocellulose filtration [32]. Protein-bound RNA 
was extracted from the nitrocellulose filters by soaking the 
minced filters in a mixture of phenol (400 ~1, pH 7) and 7 M 
urea (200 ~1) in 1.5 ml microfuge tubes for 30 min at room 
temperature, separating the phases by centrifugation and 
washing the aqueous layer with phenol and chloroform. The 
RNA was precipitated by adding one-tenth volume of 3 M 
sodium acetate (adjusted to pH 7 with acetic acid) and two 
volumes of I:1 mixture of ethanol and isopropanol. Reverse 
transcription and PCR amplification were done as described 
[31]. Cloning and sequencing of the affinity-enriched pools 
was performed using established protocols [33]. 
2 ‘-O-Methyl (2 ‘-OMe) purine nucleotide 
interference analysis 
Partially 2’-OMe-substituted oligonucleotide ligand pools were 
synthesized by the solid-phase phosphoramidite method using 
a 2:l (mol:mol) mixture of 2’-OMe:2’-OH purine nucleoside 
phosphoramidites at specified positions. Four oligonucleotide 
pools were prepared in which 3-4 defined purine nucleotide 
positions contained either a 2’-OMe or a 2’-OH group; the 
remainder are unmodified ribopurines: pool A, 5’-ACCCU- 
GAUG9GUA12GA14CGCCGGGGUG-3’ (positions contain- 
ing a mixture of 2’-OMe and 2’-OH purine, nucleotides are 
numbered); pool B, 5’-A1CCCUGA7UGGUAGACGCC- 
G19GG2rGUG-3’; pool C, 5’-ACCCUG6AUGGUAGACG- 
CCGGzoGGUGz4-3’; and pool D, 5’-ACCCUGAUGGioUA- 
G13ACG16CCGGGGUG-3’. The four pools were 5’ end- 
labeled with [Y-~~P]ATP and T4 polynucleotide kinase and 
purified by gel electrophoresis to ensure size homogeneity. 
The pools were then incubated separately with 7 and 0.7 nM 
VPF/VEGF in PBS containing 0.01 % HSA for 15 min at 
37 “C and the protein-bound ligands were selected by nitro- 
cellulose filter partitioning as described above. The affinity- 
selected and the unselected pools were subjected to partial 
alkaline hydrolysis (50 mM sodium carbonate buffer, pH 9.0, 
90 “C for lo-20 min) and the hydrolytic fragments were 
resolved on 20 % polyacrylamide denaturing gels. Dried gels 
were exposed to Fuji type BAS-111s imaging plates and the 
band intensities were quantitated on a Fuji Model BASlOOO 
Bio-imaging Analyzer.The data were normalized to the sum 
of the band intensities for each lane, and the ratio of the 
selected to the unselected normalized values was determined 
for each position. 
Apparent equilibrium dissociation constant and 
dissociation rate constant determinations 
The binding of oligonucleotide ligands at low concentrations 
to varying concentrations ofVPF/VEGF and other proteins 
was measured using the nitrocellulose filter binding assay as 
described [32,43]. Oligonucleotides for all binding experi- 
ments were purified by denaturing polyacrylamide gel 
electrophoresis and subjected to a thermal denaturation/re- 
naturation cycle as described above in binding buffer at high 
dilution (~1 r&I) prior to incubation with the protein [32,43]. 
Before partitioning on nitrocellulose filters, the binding mix- 
tures were typically incubated at 37 “C for 15 min. Some 
ligands were affinity purified on a small scale by nitrocellulose 
filtration prior to the binding experiments to remove the low 
affinity binding fractions [31]. The dissociation rate constant for 
ligands NX-178 and NX-213 were determined under pseudo 
first-order conditions by measuring the amount of 32P 5’-end- 
labeled ligands (~50 pM) bound toVPF/VEGF (17 nM) as a 
function of time following the addition of =500-fold excess of 
the unlabeled ligands, using nitrocellulose filter binding as the 
partitioning method. 
Receptor binding 
VPF/VEGF was radioiodinated by the Iodogen method [47] 
to a specific activity of l-6 x lo4 cpm ng-I. Human umbilical 
vein endothelial cells (HUVECs, population doubling 5) were 
plated in 24-well plates at a density of l-2 x lo5 cells per well 
in EGM (Clonetics, San Diego, CA). At confluence, the cells 
were incubated for 2 h at 4 “C in PBS containing 0.1% 
human serum albumin, 10 ng ml-* 1251-labeled VPF/VEGF 
and varying concentrations of the oligonucleotide ligands. At 
the end of the 2 h incubation period, the supernatant was 
aspirated and the wells were washed two times with cold PBS. 
HUVECs were then lysed with 1 % triton X-100 and the 
amount of cell-associated 1251-VPF/VEGF was determined by 
gamma counting. 
Melting temperature (T,) measurements 
Melting profiles for all oligonucleotides were obtained on a 
Gary Model 1E spectrophotometer. Oligonucleotides (0.8-40 
p.g ml-‘) were heated to 95 “C in PBS and cooled to room 
temperature prior to the melting protie determination. Melting 
profiles were generated by recording the absorbance at 260 nm 
while the sample was heated at the rate of 1 “C mm* from 
5-95 “C. The first derivative of the data points was calculated 
using the plotting program KaleidaGraph (Synergy Software, 
Reading, PA). The first derivative values were smoothed using a 
55-point smoothing function by averaging each point with 
27 data points on each side. The peak of the smoothed first 
derivative curves was used to estimate the T, values. 
NMR spectroscopy 
NMR experiments were performed on a 500 MHz Varian 
VXR-S spectrometer. The oligonucleotides were dialyzed 
with a Centricon 3 microconcentrator (Amicon, Beverly, MA) 
into the 10 mM sodium phosphate buffer (pH 7.4), 10 n&I 
sodium chloride, lyophilized and dissolved in 90 % H,O/lO % 
D,O. The spectra were collected at 5 “C with a jump and 
return sequence for solvent suppression [58] and with 
maximal excitation at the imino protons (12 ppm). 
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Determination of ligand stability in rat urine 
Ligands NX-107, NX- 178, IQ-2 13 were 5’ end-labeled with 
[Y-~~P]ATP and polynucleotide kinase and incubated at the 
concentration of 2 nM in sterile rat urine at 37 “C. The reac- 
tions were terminated at specified time points by the addition 
of 87 % aqueous formamide solution containing 25 mM 
EDTA and 0.02 % bromophenol blue, immediately frozen in 
liquid nitrogen and stored at -70 “C. Undegraded (full-length) 
ligands were separated from the degradation products by elec- 
trophoresis in 20 % polyacrylamide gels containing 7 M urea. 
The fraction of the undegraded material at each time point 
was quantitated by phosphorimager analysis as described above. 
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